Introduction to Oxytetracycline 10% Injection
In the realm of veterinary pharmaceuticals, the efficacy and reliability of broad-spectrum antibiotics are paramount for animal health and agricultural productivity. Among these, oxytetracycline 10 injection stands as a cornerstone treatment for a wide array of bacterial infections in livestock. This article delves into the critical aspects of this essential medication, exploring its technical specifications, application methodologies, manufacturing integrity, and its pivotal role in modern veterinary practice. Our focus is to provide B2B decision-makers and veterinary professionals with a comprehensive understanding of its value, supported by data and real-world applications.
Oxytetracycline, a member of the tetracycline class of antibiotics, functions by inhibiting bacterial protein synthesis, thereby demonstrating bacteriostatic action against a broad spectrum of Gram-positive and Gram-negative bacteria. The 10% injectable formulation ensures effective systemic delivery and sustained therapeutic levels, making it an indispensable tool for managing conditions such as respiratory tract infections, gastrointestinal diseases, and reproductive disorders in various animal species. The demand for high-quality, reliable `oxytetracycline 100 ml` presentations continues to grow, underscoring its importance in global animal health strategies.
Industry Trends in Veterinary Antibiotics
The veterinary pharmaceutical industry is currently navigating significant shifts driven by increasing global demand for animal protein, evolving regulatory landscapes concerning antibiotic use, and advancements in disease diagnostics. Key trends include a heightened focus on responsible antibiotic stewardship, a push for more targeted and efficient drug delivery systems, and an emphasis on compliance with international quality standards such as GMP (Good Manufacturing Practices) and ISO. There is also a growing interest in sustainable sourcing of active pharmaceutical ingredients (APIs) and environmentally friendly manufacturing processes.
Furthermore, the market for injectable antibiotics, particularly those offering convenience and broad efficacy like oxytetracycline 10 injection, remains robust. This is fueled by the need for rapid onset of action in acute infections and the practicality of administration in large animal populations. Innovations in formulation that reduce injection site reactions and extend therapeutic duration are also shaping product development. The shift towards preventative health measures and early intervention continues to drive demand for reliable and accessible veterinary medicines.
Veterinary clinics and large-scale livestock operations are increasingly seeking partners who can provide not just products, but comprehensive solutions that include technical support, supply chain reliability, and adherence to strict quality controls. The global market for animal healthcare products is projected to grow significantly, with antibiotics continuing to be a major segment, albeit with increasing scrutiny on their judicious use. This trend underscores the importance of products like oxytetracycline injection 10 that have a proven track record of safety and efficacy.
Technical Specifications and Mechanism of Action
Oxytetracycline 10 injection is formulated as a sterile, aqueous solution containing 100 mg of oxytetracycline base per milliliter. This 10% concentration ensures an optimal dosage for various species, balancing efficacy with safety and ease of administration. The active pharmaceutical ingredient (API), oxytetracycline dihydrate, is a potent broad-spectrum antibiotic.
Mechanism of Action:
Oxytetracycline exerts its bacteriostatic effect by reversibly binding to the 30S ribosomal subunit of susceptible bacteria. This binding prevents the attachment of aminoacyl tRNA to the acceptor site on the mRNA-ribosome complex, thereby inhibiting bacterial protein synthesis. This disruption ultimately impairs bacterial growth and replication. Its broad spectrum includes many Gram-positive bacteria (e.g., Staphylococcus aureus, Streptococcus spp.) and Gram-negative bacteria (e.g., Pasteurella spp., E. coli, Salmonella spp.), as well as some protozoa, rickettsiae, and chlamydiae.
Pharmacokinetics:
Upon intramuscular or subcutaneous administration, oxytetracycline is readily absorbed, achieving peak plasma concentrations within 2 to 6 hours. It distributes widely throughout body tissues and fluids, with therapeutic levels maintained for approximately 24-48 hours depending on the formulation and species. Elimination primarily occurs via the kidneys (glomerular filtration) and, to a lesser extent, through bile. The half-life varies across species, generally ranging from 6 to 12 hours. The high bioavailability of the 10% solution ensures effective systemic reach against deep-seated infections.
Product Specification Table: Oxytetracycline 10% Injection
| Parameter | Specification |
|---|---|
| Active Ingredient | Oxytetracycline Dihydrate |
| Concentration | 100 mg/mL (10% w/v) |
| Appearance | Clear, yellow to amber sterile solution |
| Packaging Volume | 50 mL, 100 mL, 250 mL, 500 mL |
| Route of Administration | Intramuscular (IM), Subcutaneous (SC) |
| Target Species | Cattle, Swine, Sheep, Goats, Poultry |
| Withdrawal Period (Meat) | Species-dependent, typically 14-28 days |
| Withdrawal Period (Milk) | Species-dependent, typically 3-7 days |
| Storage Conditions | Store below 25°C, protect from light. Do not freeze. |
| Shelf Life | Typically 2-3 years from manufacturing date |
Manufacturing Process Flow of Oxytetracycline 10% Injection
The production of oxytetracycline 10 injection adheres to stringent Good Manufacturing Practices (GMP) and international standards such as ISO 9001 and relevant pharmacopoeial guidelines (e.g., USP, BP). This multi-stage process ensures product purity, sterility, and consistent therapeutic efficacy.
Key Process Steps:
- 1. Raw Material Sourcing & QC: High-grade oxytetracycline dihydrate API is sourced from approved suppliers. Excipients, including solvents, pH adjusters, and stabilizers, are also rigorously tested for identity, purity, and compliance with pharmacopoeial standards (e.g., water for injection, propylene glycol, magnesium chloride).
- 2. Solution Preparation & Mixing: The API and excipients are precisely weighed and dissolved in sterile Water for Injection (WFI) within validated stainless steel mixing tanks. Critical parameters such as pH, temperature, and mixing speed are meticulously controlled to ensure homogeneity and stability of the 10% solution.
- 3. Primary Filtration: The bulk solution undergoes a primary filtration step to remove any particulate matter. This typically involves depth filtration or membrane filtration through progressively finer filters to prepare for sterilization.
- 4. Sterile Filtration: The solution is then subjected to aseptic sterile filtration through 0.22-micron filters in a Class 100 (ISO 5) cleanroom environment. This critical step ensures the removal of bacteria and other microorganisms, rendering the solution sterile. Filters are integrity tested before and after use.
- 5. Aseptic Filling & Sealing: The sterile solution is aseptically filled into pre-sterilized glass vials (e.g., `oxytetracycline 100 ml` or other sizes) within the Class 100 cleanroom. Vials are immediately sealed with sterile rubber stoppers and aluminum crimps. This phase is monitored continuously for environmental parameters and personnel compliance.
- 6. Visual Inspection: Each filled vial undergoes meticulous visual inspection for particulate matter, cracks, fill volume, and proper sealing. Automated inspection systems are often used to ensure consistency and eliminate human error.
- 7. Secondary Packaging & Labeling: Accepted vials are labeled with essential information including product name (oxytetracycline injection 10), concentration, batch number, expiry date, and storage instructions. They are then packaged into cartons with accompanying leaflets.
- 8. Final Quality Control & Release: Before release, samples from each batch undergo comprehensive testing, including sterility tests (USP ), endotoxin tests (USP ), assay for active ingredient content (HPLC), pH, related substances, and physical stability tests. Only batches meeting all specifications are released for distribution.
The entire process is validated and routinely audited to ensure compliance with international pharmaceutical manufacturing standards. This commitment to quality assures a reliable service life for the product, with a typical shelf life of 2-3 years when stored correctly. Target industries for this product include veterinary clinics, large-scale livestock farms (beef, dairy, swine, poultry), and animal pharmaceutical distributors. The rigorous process guarantees a product with consistent potency, stability, and sterility, offering significant advantages in disease management.
Application Scenarios & Target Industries
Oxytetracycline 10 injection is a versatile and essential antibiotic in modern veterinary medicine, indicated for the treatment and control of a broad range of bacterial diseases across multiple livestock species. Its broad-spectrum activity makes it suitable for both prophylactic and therapeutic applications in various animal production systems.
Primary Application Scenarios:
- Cattle: Effective against Bovine Respiratory Disease (BRD) complex associated with Pasteurella spp., anaplasmosis, foot rot, calf diphtheria, acute mastitis, metritis, and bacterial enteritis. It's often used in feedlot operations and dairy farms.
- Swine: Indicated for bacterial enteritis (scours), pneumonia, leptospirosis, erysipelas, and atrophic rhinitis. Crucial for herd health management in pig farming.
- Sheep and Goats: Used for treatment of pneumonia, bacterial enteritis, foot rot, mastitis, and certain reproductive infections. Essential for small ruminant health.
- Poultry: Although less common as an injection for large flocks, it can be used for individual bird treatment for fowl cholera and infectious coryza.
Advantages in Typical Application Scenarios:
- Broad-Spectrum Efficacy: Treats a wide variety of bacterial pathogens, simplifying treatment protocols and reducing the need for multiple different antibiotics.
- Rapid Action: Injectable format ensures quick absorption and distribution, leading to faster therapeutic onset, which is critical in acute infections.
- Cost-Effectiveness: A well-established and economically viable solution, providing significant value in large-scale animal production.
- Reduced Treatment Cycles: The sustained action of oxytetracycline 10 injection formulations often allows for fewer injections, minimizing stress on animals and labor costs.
- Versatility: Suitable for individual animal treatment or group treatment protocols where indicated, offering flexibility in farm management.
Target industries include commercial livestock operations, dairy farms, feedlots, veterinary clinics, and animal health distributors. The reliability of oxytetracycline 100 ml packaging ensures that veterinary professionals have a potent and readily available treatment option for common and economically impactful diseases.
Technical Advantages and Quality Assurance
The enduring relevance of oxytetracycline 10 injection in veterinary medicine is largely attributable to its robust technical advantages and the stringent quality assurance protocols employed in its manufacturing.
Key Technical Advantages:
- Proven Efficacy: Decades of veterinary use have firmly established oxytetracycline's effectiveness against a broad range of bacterial pathogens, minimizing the risk of treatment failure.
- High Bioavailability: The 10% injectable formulation ensures excellent systemic absorption and distribution, reaching therapeutic concentrations rapidly in target tissues. This is crucial for treating systemic infections.
- Sustained Therapeutic Levels: The formulation is designed to maintain effective drug concentrations over an extended period (typically 24-48 hours), reducing the frequency of administration and improving animal welfare.
- Reduced Resistance Development (with judicious use): As a well-understood antibiotic, proper dosing and adherence to withdrawal times help mitigate the development of antimicrobial resistance, contributing to responsible antibiotic stewardship.
- Formulation Stability: Manufactured under controlled conditions, the product exhibits excellent chemical stability, ensuring its potency remains consistent throughout its shelf life.
- Ease of Administration: The sterile solution is designed for straightforward intramuscular or subcutaneous injection, making it practical for field veterinarians and farm personnel.
Quality Assurance and Compliance:
Our commitment to quality is foundational. Every batch of oxytetracycline 10 injection is manufactured in facilities that adhere strictly to current Good Manufacturing Practices (cGMP) as regulated by bodies such as the FDA (for products sold in the US) or EMA (for Europe), and often complies with national pharmacopoeias (e.g., USP, BP). Our production facilities are ISO 9001 certified, demonstrating a robust quality management system.
This includes comprehensive testing at every stage, from raw material procurement to finished product release. Analytical methods like High-Performance Liquid Chromatography (HPLC) are used to precisely quantify the active ingredient and detect impurities. Sterility, pH, clarity, and particulate matter tests are standard. This rigorous approach ensures that each vial of oxytetracycline injection 10 meets the highest standards of safety, efficacy, and purity, reinforcing trust among our global clientele in the veterinary sector. Our years of service in the animal health industry attest to our consistent delivery of high-quality veterinary pharmaceuticals.
Vendor Comparison and Competitive Edge
When selecting a supplier for essential veterinary pharmaceuticals like oxytetracycline 10 injection, B2B clients prioritize several critical factors beyond just price. These include product quality, regulatory compliance, supply chain reliability, technical support, and the potential for customized solutions.
Product Comparison Table: Key Differentiators for Oxytetracycline 10% Injection
| Feature/Attribute | Our Oxytetracycline 10% Injection | Typical Generic Oxytetracycline 10% |
|---|---|---|
| Regulatory Approvals | GMP-certified, ISO 9001, compliant with major pharmacopoeias (USP/BP/EP). Registered in multiple markets. | Variable; may only meet local standards or have limited international certifications. |
| API Purity & Origin | ≥98.5% purity, sourced from audited, premium suppliers with full traceability. | May vary; purity could be lower, and origin may not be fully disclosed or audited to the same extent. |
| Formulation Stability | Advanced excipient blend for enhanced shelf life and minimal degradation, tested through accelerated stability studies. | Basic formulation; potential for reduced stability over time, leading to shorter effective shelf life. |
| Injection Site Reaction | Optimized pH and osmolality to minimize local tissue irritation and swelling. | Higher incidence of local reactions due to less refined formulation. |
| Packaging Quality | Type I pharmaceutical glass vials, butyl rubber stoppers, robust aluminum crimp seals. | Lower grade glass, stoppers, or seals, potentially leading to contamination or leakage. |
| Technical Support | Dedicated veterinary technical support team, comprehensive documentation, and training available. | Often limited to basic product information, lacking in-depth veterinary expertise. |
Our competitive advantage lies not only in the superior quality and robust manufacturing of our oxytetracycline injection 10 but also in our holistic approach to client partnerships. We offer transparent supply chains, consistent product availability, and a responsive customer service infrastructure. This ensures that our partners receive a product that is not only effective but also backed by unparalleled support and reliability, vital for the demanding needs of the animal health sector.
Customized Solutions and Partnering Opportunities
Recognizing the diverse requirements of our B2B partners, we offer flexible and customized solutions for our oxytetracycline 10 injection product line. Our goal is to forge strong, long-term relationships by adapting to specific market demands and operational needs.
Customization Options:
- Packaging Variants: While `oxytetracycline 100 ml` is a standard offering, we can accommodate requests for alternative vial sizes (e.g., 50 mL, 250 mL, 500 mL) to suit different market segments or large-volume users.
- Private Labeling & Branding: For distributors and large agricultural cooperatives, we offer private labeling services, allowing partners to market our high-quality product under their own brand. This includes custom label design and packaging tailored to specific brand guidelines.
- Bulk Supply & Logistics: We provide solutions for bulk procurement and streamlined logistics, ensuring efficient and timely delivery to global destinations. Our expertise in international shipping regulations for veterinary pharmaceuticals minimizes customs delays and ensures product integrity.
- Regulatory Support: Our team can assist partners with market-specific registration requirements and documentation for oxytetracycline 10 injection, facilitating smooth market entry and compliance.
- Formulation Adaptations (within regulatory limits): While the core formulation remains consistent for efficacy, minor excipient adjustments might be considered for specific climatic conditions or regional preferences, subject to regulatory approval and stability testing.
Our collaborative approach ensures that each partnership is uniquely structured to optimize mutual benefits. We pride ourselves on being more than just a supplier; we aim to be a strategic partner in animal health, offering products like oxytetracycline injection 10 that meet the highest global standards while addressing localized needs.
Application Case Studies
Real-world application demonstrates the tangible benefits of oxytetracycline 10 injection in veterinary practice.
Case Study 1: Bovine Respiratory Disease (BRD) Outbreak in a Feedlot
Background: A large feedlot experienced an outbreak of Bovine Respiratory Disease affecting 15% of its newly arrived cattle. Clinical signs included fever, coughing, nasal discharge, and reduced feed intake. Diagnostic tests confirmed Pasteurella multocida as a primary pathogen.
Intervention: Veterinary staff initiated treatment with oxytetracycline 10 injection at a dose of 10 mg/kg body weight, administered intramuscularly to affected animals for three consecutive days. Prophylactic treatment was also applied to at-risk animals.
Outcome: Within 48 hours, a significant reduction in fever and improved respiratory function were observed in 85% of treated animals. The overall recovery rate was 92%, with a mortality rate of less than 1%. The prompt and effective action of the oxytetracycline injection 10 minimized the economic impact of the outbreak, demonstrating its critical role in managing herd health.
Case Study 2: Swine Erysipelas Management in a Breeding Farm
Background: A commercial pig breeding farm reported several cases of erysipelas, characterized by diamond-skin lesions, high fever, and lethargy in growing pigs. The infection, caused by Erysipelothrix rhusiopathiae, posed a threat to the breeding stock and market pigs.
Intervention: Following confirmation, oxytetracycline 10 injection was administered intramuscularly at a dose of 10 mg/kg body weight once daily for 5 days to clinically affected animals. Sanitation protocols were also reinforced.
Outcome: Treated pigs showed rapid improvement in clinical signs within 24-36 hours, with diamond lesions fading and temperatures returning to normal. The recovery rate for treated animals was over 95%, preventing further spread of the disease and maintaining productivity on the farm. The use of `oxytetracycline 100 ml` vials facilitated efficient and consistent dosing across the affected groups.
Trustworthiness: FAQ, Lead Time, Warranty & Support
Frequently Asked Questions (FAQ):
Q: What is the primary use of Oxytetracycline 10% Injection?
A: It is a broad-spectrum antibiotic primarily used for the treatment of bacterial infections in cattle, swine, sheep, and goats, including respiratory, gastrointestinal, urinary, and reproductive tract infections, as well as certain other bacterial and rickettsial diseases.
Q: What is the recommended dosage for cattle?
A: The general dosage for cattle is 10 mg/kg body weight, administered by intramuscular or subcutaneous injection. For specific conditions or prolonged effects, veterinary consultation and product leaflet instructions should be followed.
Q: What are the withdrawal periods for meat and milk?
A: Withdrawal periods vary by species and region. Typically, for cattle, it's 28 days for meat and 7 days for milk. Always refer to the specific product label and local regulatory guidelines for accurate withdrawal times to ensure food safety.
Q: How should oxytetracycline 10 injection be stored?
A: Store in a cool, dry place below 25°C, protected from direct sunlight. Do not freeze. Ensure the vial is tightly sealed after use.
Lead Time and Fulfillment Details:
We maintain robust production capacities and efficient supply chain logistics to ensure timely fulfillment of orders. Standard lead times for oxytetracycline 10 injection typically range from 2 to 4 weeks, depending on order volume, customization requirements, and destination. For large-scale or recurring orders, we work closely with partners to establish optimized inventory and shipping schedules. Expedited shipping options are available upon request and feasibility assessment. Our global distribution network ensures reliable delivery to various international markets.
Warranty Commitments:
We stand behind the quality and efficacy of our oxytetracycline 10 injection products. All products are warranted to conform to the specifications outlined in their respective Certificates of Analysis and to be free from defects in materials and manufacturing under normal use and storage conditions, for the duration of their stated shelf life. Our warranty is backed by our adherence to GMP standards and our comprehensive internal quality control processes. Any product found not to meet these standards will be promptly addressed.
Customer Support and After-Sales Service:
Our commitment extends beyond product delivery. We offer comprehensive customer support, including technical assistance from our team of veterinary experts, to answer questions regarding product application, dosage, and disease management. Our dedicated sales and support teams are available during business hours to assist with orders, logistics, and any post-purchase inquiries. We provide detailed product documentation, including Material Safety Data Sheets (MSDS) and Certificates of Analysis (CoA), to ensure full transparency and compliance for our partners. Your success in animal health is our priority.
Conclusion
Oxytetracycline 10 injection remains an indispensable therapeutic agent in veterinary medicine, critical for maintaining animal health and productivity across various livestock sectors. Its established broad-spectrum efficacy, coupled with meticulous manufacturing processes adhering to global quality standards, ensures its reliability and safety. By providing detailed technical specifications, transparent production methodologies, and robust customer support, we empower veterinary professionals and B2B partners to make informed decisions. We are committed to delivering high-quality, effective veterinary pharmaceuticals that contribute to sustainable animal agriculture and global food security.
References
- United States Pharmacopeia (USP) - Monographs for Oxytetracycline Injection.
- British Pharmacopoeia (BP) - Monographs for Oxytetracycline Injection.
- Good Manufacturing Practices (GMP) Guidelines for Veterinary Medicinal Products.
- World Organisation for Animal Health (OIE) - Guidelines on Antimicrobial Resistance.
- Journal of Veterinary Pharmacology and Therapeutics - Articles on Oxytetracycline Pharmacokinetics.
Post time: October 6, 2025
